4//SEC Filing
Alder Matthias 4
Accession 0001209191-23-051502
CIK 0001819411other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 4:36 PM ET
Size
7.2 KB
Accession
0001209191-23-051502
Insider Transaction Report
Form 4
Alder Matthias
CHIEF OPERATING OFFICER
Transactions
- Exercise/Conversion
Common Stock
2023-10-01+825→ 6,675 total - Exercise/Conversion
Restricted Stock Units
2023-10-01−825→ 9,075 total→ Common Stock (825 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
- [F2]The RSUs vested 25% on July 1, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.
Documents
Issuer
Gain Therapeutics, Inc.
CIK 0001819411
Entity typeother
Related Parties
1- filerCIK 0001370820
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 4:36 PM ET
- Size
- 7.2 KB